Carregando...
Comparative evaluation of the new FDA approved THxID™-BRAF test with high resolution melting and sanger sequencing
BACKGROUND: Since patients diagnosed with BRAF V600E and V600K mutated advanced melanoma show response to treatment with MAP kinase inhibitors, several sensitive methods have been developed to determine the V600 allele status of melanoma patients. Vemurafenib (Zelboraf) and dabrafenib (Tafinlar) are...
Na minha lista:
| Publicado no: | BMC Cancer |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4223712/ https://ncbi.nlm.nih.gov/pubmed/25037456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-519 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|